SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Back to INDV Full portfolio

Position in INDV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,879,756

New position

Shares Held

160,097

first reported quarter

Ownership

0.131%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Derivatives in INDV

reported options exposure · as of Mar 31, 2026

CallValue

$5,029,200

CallShares

165,000

PutValue

$5,492,496

PutShares

180,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $328,512,917 across 53 Drug Manufacturers - Specialty & Generic names. INDV ranks #13 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	634,564	$75,011,810
2	LQDA	Liquidia Corp	1,001,081	$37,780,796
3	HIMS	Hims & Hers Health, Inc.	1,634,741	$33,937,222
4	BCRX	Biocryst Pharmaceuticals Inc	2,815,304	$26,801,694
5	TEVA	Teva Pharmaceutical Industries Ltd	739,515	$22,274,191
6	KNSA	Kiniksa Pharmaceuticals International, plc	383,811	$18,480,499
7	UTHR	UNITED THERAPEUTICS Corp	29,696	$17,609,134
8	HROW	Harrow, Inc.	457,782	$16,141,393

All Filings in INDV

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,029,200	165,000	+3.1%	Call	Other	2026-05-15
2026-03-31	$4,879,756	160,097	-11.2%	Shares	Other	2026-05-15
2026-03-31	$5,492,496	180,200	—	Put	Other	2026-05-15
No filing history on record for this holder in this stock.